SCHEDULE OF ACTIVITY OF THE WARRANTS (Details) |
6 Months Ended |
---|---|
Jun. 30, 2025
USD ($)
$ / shares
shares
| |
Equity [Abstract] | |
Number of warrants, Beginning balance | shares | |
Weighted average exercise price, Beginning balance | $ / shares | |
Fair value, Beginning balance | $ | |
Number of warrants, Granted | shares | 13,116,256 |
Weighted average exercise price, Granted | $ / shares | $ 3.828 |
Weighted average remaining life (years), Granted | 2 years 3 months |
Fair value of warrant | $ | $ 35,419,867 |
Number of warrants, Exercised | shares | |
Weighted average exercise price, Exercised | $ / shares | |
Number of warrants, Forfeited/canceled | shares | |
Weighted average exercise price, Forfeited/canceled | $ / shares | |
Number of warrants, Ending balance | shares | 13,116,256 |
Weighted average exercise price, Ending balance | $ / shares | $ 3.828 |
Weighted average remaining life (years) | 2 years 1 month 28 days |
Fair value, Ending balance | $ | $ 28,194,538 |
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments grants in period fair value. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments grants in period weighted average remaining contractual terms. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments exercises in period weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments forfeitures in period weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments grants in period weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments fair value. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|